An increasing number of people are taking the drug commonly used to treat parasites in animals. Veterinary and infectious disease expert Dr. Gerald Parker says vaccines remain a safe and effective way to protect against the virus.
A Texas A&M expert explains what's next for the COVID-19 crisis, from FDA approvals and booster shots to the fight against new variants.
A discovery by Wenshe Ray Liu and his team leads to an agreement with a California biopharmaceutical company.
Houston residents can now participate in the study, which aims to determine how effective vaccines are at preventing transmission of the virus.
Experts on vaccines, infectious diseases and global health describe the latest stage of the pandemic.
Texas A&M virologist Benjamin Neuman discusses how the coronavirus variant could affect the U.S.
Any student who has not tested positive for SARS-CoV-2 and has not received a vaccine might be eligible to participate.
A panel of experts recently discussed COVID-19, vaccines, and predictions for future variants during a virtual event.
A single case led to only mild symptoms. The variant is named BV-1 for its Brazos Valley origin.
The collaborative study shows enzyme inhibitor K777 is effective in combatting SARS-CoV-2.